Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graciaa

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2025
From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation UnitsDavid M Dobrzynski, Daniel S Graciaa, Tara M Babu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 12, 2013
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findingsDominique Musselman, Erica B Royster, Ming Wang, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2022
Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant TuberculosisDaniel S Graciaa, Maia Kipiani, Matthew J Magee, et al.
Health Technology Assessment (Winchester, England)|November 2, 2024
Timing of Stoma Closure in Neonates: the ToSCiN mixed-methods studyNick Lansdale, Kerry Woolfall, Elizabeth Deja, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|December 9, 2022
Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January-March 2021Daniel S Graciaa, Hans P Verkerke, Jeannette Guarner, et al.
Haematologica|December 1, 2020
Eculizumab for complement mediated thrombotic microangiopathy in sickle cell diseaseSatheesh Chonat, Sara Graciaa, H Stella Shin, et al.
Blood|August 23, 2021
T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndromeDeepak Kumar, Chengyu Prince, Carolyn M Bennett, et al.
MMWR. Morbidity and Mortality Weekly Report|June 29, 2018
Outbreaks Associated with Untreated Recreational Water - United States, 2000-2014Daniel S Graciaa, Jennifer R Cope, Virginia A Roberts, et al.
Vaccine|September 10, 2025
Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trialDavid J Diemert, Daniel S Graciaa, Bo Zhang, et al.
The Lancet. Infectious Diseases|June 30, 2026
Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trialNadine Rouphael, Shahida Baqar, Michelle Dickey, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2025
From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation UnitsDavid M Dobrzynski, Daniel S Graciaa, Tara M Babu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 12, 2013
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findingsDominique Musselman, Erica B Royster, Ming Wang, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2022
Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant TuberculosisDaniel S Graciaa, Maia Kipiani, Matthew J Magee, et al.
Health Technology Assessment (Winchester, England)|November 2, 2024
Timing of Stoma Closure in Neonates: the ToSCiN mixed-methods studyNick Lansdale, Kerry Woolfall, Elizabeth Deja, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|December 9, 2022
Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January-March 2021Daniel S Graciaa, Hans P Verkerke, Jeannette Guarner, et al.
Haematologica|December 1, 2020
Eculizumab for complement mediated thrombotic microangiopathy in sickle cell diseaseSatheesh Chonat, Sara Graciaa, H Stella Shin, et al.
Blood|August 23, 2021
T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndromeDeepak Kumar, Chengyu Prince, Carolyn M Bennett, et al.
MMWR. Morbidity and Mortality Weekly Report|June 29, 2018
Outbreaks Associated with Untreated Recreational Water - United States, 2000-2014Daniel S Graciaa, Jennifer R Cope, Virginia A Roberts, et al.
Vaccine|September 10, 2025
Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trialDavid J Diemert, Daniel S Graciaa, Bo Zhang, et al.
The Lancet. Infectious Diseases|June 30, 2026
Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trialNadine Rouphael, Shahida Baqar, Michelle Dickey, et al.
Pageof 7